- ►nih.gov - Free from Publisher SA Rowley, S Vijayasekaran, PK Yu, IL … - British Journal of Ophthalmology, 2004 - bjo.bmj.com Results: No evidence of retinal toxicity was seen with tenecteplase doses up to
and including 50 μg. At a dose of 150 μg ophthalmoscopy was normal, but
histology showed mild retinal damage in the inner nuclear layer and ... Cited by 6 - Related articles - BL Direct - All 10 versions
[CITATION] Guidelines for intravitreal treatment of vascular occlusions with rtPA
IL McAllister, S Vijayasekaran, CH Khong, DY … - Clinical & experimental ophthalmology, 2006 - ncbi.nlm.nih.gov PURPOSE: To investigate the safety of the thrombolytic agent, tenecteplase to
the outer retina in pig eyes. METHODS: Tenecteplase (50 microg) was injected
into the subretinal space in one eye while the fellow eye received balanced ... Related articles - BL Direct - All 2 versions
TOFIF MEMBRANES - oftalmo.com Método: Inyección de 0,1 ml (25 µg) de tenecteplase en cámara anterior en 10
pacientes que presentaban membranas fibrinoides severas que no respondieron al
tratamiento corticoideo tras cirugía de cataratas (n=8), trabeculectomía ... Related articles - Cached
ILMA FRANZCO, SV PhD, CH Khong, DYY … - Clinical & Experimental Ophthalmology - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Related articles
CM Gibson, SJ Marble - Clinical Cardiology, 2001 - interscience.wiley.com While thrombolytic agents have demonstrated improved mortality over the use of
placebo, this has come at the expense of bleeding complications such as
intracranial hemorrhage (ICH). Tenecteplase (TNK-tPA) is a novel ... Cited by 15 - Related articles - BL Direct - All 4 versions
Y Oshima, M Ohji, Y Tano - British Medical Journal, 2006 - bjo.bmj.com Online First articles must include the digital object identifier (DOIs) and date
of initial publication. establish publication priority; they are indexed by
PubMed from initial publication. Citations to may be posted when available ... Cited by 1 - Related articles - All 2 versions
G Rudolph, P Kalpadakis - Graefe's Archive for Clinical and Experimental …, 2002 - Springer Dear Sir, We appreciate the interesting article in which Jurklies and colleagues
present results of multifocal electro- retinography in patients with neovas-
cular maculopathy [3]. The study raises a number of questions but pro- ... Cited by 9 - Related articles - BL Direct - All 2 versions
Y Goto, T Taniwaki, J Shigematsu, S … - Clinical Neurophysiology, 2003 - Elsevier Results: There were no significant changes in the 4 groups on Day 30. On Day
180, the amplitudes of a- and b-waves of dark-adapted (DA) ERGs were reduced in
the PHT group compared with those of the control group. In the VPA group, ... Cited by 3 - Related articles - All 10 versions
[CITATION] Clinical Aspects of Miltefosine and Its Topical Formulation Miltex
